Conditions & Health

Inflammatory bowel disease

Chronic inflammatory conditions of the gastrointestinal tract, including Crohn’s disease and ulcerative colitis. BPC-157 and KPV show anti-inflammatory effects in preclinical IBD models.

Frequently Asked Questions

What is Inflammatory bowel disease?

Chronic inflammatory conditions of the gastrointestinal tract, including Crohn’s disease and ulcerative colitis. BPC-157 and KPV show anti-inflammatory effects in preclinical IBD models.

Why is Inflammatory bowel disease important in peptide research?

Understanding inflammatory bowel disease is important because it represents a health condition where peptide interventions are being actively researched. Knowledge of the underlying pathology helps inform peptide selection and protocol design.

Related Terms

Inflammation

The body’s immune response to injury, infection, or irritation. Acute inflammation is protective; chronic inflammation drives disease. Many peptides (BPC-157, KPV, LL-37, Thymosin Alpha-1) modulate inflammatory pathways.

Leaky gut

Increased intestinal permeability allowing bacteria, toxins, and undigested food particles to pass through the gut lining. BPC-157 has been shown to restore gut barrier integrity in animal models.

Related Peptide Profiles

BPC-157

Body Protection Compound-157, a synthetic pentadecapeptide derived from human gastric juice studied for tissue repair, gut healing, and anti-inflammatory effects.

KPV

A tripeptide (Lys-Pro-Val) derived from alpha-MSH with potent anti-inflammatory properties, studied for gut health and skin conditions.

← Back to full glossary